Handelsinvest Investeringsforvaltning’s Aerie Pharmaceuticals AERI Stock Holding History

Handelsinvest Investeringsforvaltning’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-90,000	Closed	-$1.33M	–	128
2020 Q2	$1.33M	Hold	90,000	–	–	0.28%	77
2020 Q1	$1.22M	Buy	90,000 +30,000	+50%	+$569K	0.32%	73
2019 Q4	$1.45M	Hold	60,000	–	–	0.29%	73
2019 Q3	$1.15M	Hold	60,000	–	–	0.25%	70
2019 Q2	$1.77M	Hold	60,000	–	–	0.37%	63
2019 Q1	$2.85M	Buy	60,000 +14,700	+32%	+$647K	0.63%	49
2018 Q4	$1.64M	Hold	45,300	–	–	0.41%	56
2018 Q3	$2.79M	Hold	45,300	–	–	0.57%	49
2018 Q2	$3.06M	Hold	45,300	–	–	0.67%	48
2018 Q1	$2.46M	Hold	45,300	–	–	0.55%	46
2017 Q4	$2.71M	Hold	45,300	–	–	0.6%	48
2017 Q3	$2.2M	Hold	45,300	–	–	0.52%	45
2017 Q2	$2.38M	Buy	+45,300	New	+$2.11M	0.6%	40

Other funds holding AERI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return

Handelsinvest Investeringsforvaltning's AERI Position: Q3 2020 in Review

Handelsinvest Investeringsforvaltning sold out of Aerie Pharmaceuticals (AERI) in Q3 2020, closing a stake of 90,000 shares — an estimated $1.33M sold.

Handelsinvest Investeringsforvaltning first reported a position in AERI in Q2 2017 and held it in 13 quarters. The position peaked at $3.06M in Q2 2018. 148 funds tracked by Wall St. Rank hold AERI as of Q3 2020.

Handelsinvest Investeringsforvaltning reported no remaining Aerie Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
Handelsinvest Investeringsforvaltning sold 90,000 Aerie Pharmaceuticals shares in Q3 2020, an estimated $1.33M.
Handelsinvest Investeringsforvaltning first reported a position in Aerie Pharmaceuticals in Q2 2017 and held it in 13 quarters.
Handelsinvest Investeringsforvaltning's Aerie Pharmaceuticals position peaked at $3.06M in Q2 2018.
148 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2020.

Based on Handelsinvest Investeringsforvaltning's 13F filing for Q3 2020, filed 26 Oct 2020.